Peptide purity: what does 99% HPLC mean?
Peptide purity explained: what does an HPLC percentage really indicate?
For research peptides, a purity percentage is often stated. Values such as 98%, 99% or 99.5% purity are regularly used to describe the quality of a peptide.
A high percentage seems easy to interpret: the higher the number, the better the product. In practice, peptide purity is more complex.
An HPLC result provides information about the relative composition of an analyzed sample. However, the percentage does not automatically prove:
- that the correct peptide is present;
- that the amino acid sequence is completely correct;
- that the stated amount of peptide in the vial is correct;
- that the material is sterile;
- that it is free of endotoxins;
- that all possible contaminants have been measured.
To assess peptide quality carefully, multiple analytical data points must be considered together.
In this blog, we discuss how peptide purity is measured, what an HPLC percentage means, and why purity is only one part of complete quality control.
What does peptide purity mean?
Peptide purity describes the proportion of detected peptide-related components that corresponds to the main component in the analyzed sample.
For example, when a certificate of analysis lists an HPLC purity of 99% states, this generally means that approximately 99% of the integrated chromatographic signal has been assigned to the main peak.
This does not automatically mean that 99% of the total weight in the vial consists of the desired peptide.
A vial may contain other components in addition to the peptide, such as:
- water;
- counterions;
- salts;
- excipients;
- residual products from production;
- undetectable components.
The HPLC percentage and the actual amount of peptide are therefore different quality parameters.
What is HPLC?
HPLC stands for High-Performance Liquid Chromatography.
It is an analytical technique used to separate different chemical components in a sample.
During an HPLC analysis, a dissolved sample is passed through a column. This column contains a stationary phase.
The liquid flowing through the column is called the mobile phase.
The different molecules do not all interact with these phases in the same way. As a result, some components move through the column faster than others.
The result is displayed in a chromatogram.
A chromatogram usually consists of:
- a horizontal time axis;
- a vertical signal axis;
- one or more peaks.
Each peak represents a detected component or group of components.
What is a retention time?
The time required for a component to travel through the HPLC column and reach the detector is called the retention time.
The retention time can be affected by:
- type of HPLC column;
- mobile-phase composition;
- temperature;
- flow rate;
- properties of the peptide;
- analytical method used.
A corresponding retention time can help with comparison to a reference standard.
However, retention time alone is usually insufficient to definitively confirm the identity of a peptide.
Different molecules can have similar retention times under certain conditions.
Therefore, HPLC is often combined with mass spectrometry.
How is the purity percentage calculated?
In many HPLC analyses, the area under each chromatographic peak is calculated.
This is called peak-area integration.
A simplified example:
- main peak: 99%;
- secondary peak A: 0.5%;
- secondary peak B: 0.3%;
- other detected peaks: 0.2%.
The reported chromatographic purity is then approximately 99%.
This calculation depends on:
- detection method;
- integration settings;
- selected wavelength;
- analytical method;
- limit of detection;
- sample concentration.
A purity percentage should therefore always be interpreted in the context of the method used.
What does a main peak mean?
The largest peak in a chromatogram is often called the main peak.
For a well-characterized peptide, this peak is expected to correspond to the desired peptide.
However, this must be confirmed analytically.
A large peak does not by itself prove that the correct molecular structure is present.
To support identification, additional techniques may be used, such as:
- mass spectrometry;
- amino acid analysis;
- sequence analysis;
- nuclear magnetic resonance;
- comparison with a reference standard.
HPLC primarily describes the chromatographic composition of the sample.
What impurities can arise during peptide synthesis?
Many synthetic peptides are produced via solid-phase peptide synthesis, usually abbreviated as SPPS.
During this process, amino acids are sequentially coupled to a growing peptide chain.
Minor process deviations can occur at each step.
Possible peptide-related impurities include:
Shortened peptide chains
When an amino acid is not coupled correctly, an incomplete peptide chain may form.
This is also called a truncation product.
Deletion sequences
In a deletion sequence, one or more amino acids are missing from the intended chain.
As a result, the molecular mass differs from that of the desired peptide.
Chemically modified variants
Chemical changes can occur during production, purification, or storage.
Examples include:
- oxidation;
- deamidation;
- hydrolysis;
- isomerization.
Protecting group residues
During peptide synthesis, temporary protecting groups are used to prevent unwanted reactions.
These must be removed later.
Incomplete removal can contribute to secondary components.
Aggregates
Peptide molecules can form larger structures under certain conditions.
Not every HPLC method detects or characterizes aggregation in the same way.
Is 99% HPLC purity the same as 99% peptide content?
No.
This is an important distinction.
HPLC purity usually describes the relative proportion of detected chromatographic components.
Peptide content describes how much actual peptide is present relative to the total material.
For example, a lyophilized vial may contain:
- the desired peptide;
- water;
- counterions;
- salts;
- excipients.
These components are not necessarily all measured in the same way during a standard HPLC analysis.
Therefore, a sample may have high chromatographic purity while its total peptide content is lower than the HPLC percentage.
Additional analytical methods are needed for quantitative determination.
What is peptide assay?
An assay is used to determine the amount or concentration of a specific component.
Depending on the research objective, different methods can be used.
Examples include:
- quantitative HPLC with a reference standard;
- amino acid analysis;
- nitrogen analysis;
- spectroscopic techniques;
- mass balance calculations.
An assay answers a different question than a standard purity analysis.
Purity analysis asks:
What proportion of the detected peptide components belongs to the main peak?
A quantitative assay requires:
How much of the desired peptide is actually present?
Both data sets may be relevant for complete quality characterization.
Why is mass spectrometry important?
Mass spectrometry, often abbreviated as MS, measures the mass-to-charge ratio of ionized molecules.
In peptide analysis, it can be determined whether the measured molecular mass corresponds to the theoretically expected mass.
Mass spectrometry can contribute to:
- identity confirmation;
- detection of certain modifications;
- analysis of degradation products;
- comparison of peptide variants.
When the measured mass matches the expected mass, this supports the identification.
However, mass spectrometry does not automatically provide complete information about:
- purity percentage;
- exact quantity;
- sterility;
- endotoxins;
- biological activity.
Therefore, HPLC and mass spectrometry complement each other.
What is LC-MS?
LC-MS combines liquid chromatography with mass spectrometry.
First, components are separated chromatographically. The individual signals are then examined further using mass spectrometry.
This combination can provide information about:
- retention time;
- molecular mass;
- potential impurities;
- degradation products;
- chemical modifications.
LC-MS can therefore provide more analytical information than a single individual technique.
The quality of the results remains dependent on:
- sample preparation;
- instrument settings;
- method validation;
- reference materials;
- expert interpretation.
Why can different laboratories measure different results?
The same peptide may produce slightly different results at different laboratories.
Possible causes include:
- different HPLC columns;
- different mobile phases;
- deviating gradients;
- different detection wavelengths;
- differences in sample preparation;
- different integration settings;
- instrument variation.
A difference does not automatically mean that one analysis is incorrect.
To compare results properly, the analytical method must also be considered.
A percentage without information about the method provides only limited context.
What is method validation?
An analytical method must be demonstrably suitable for its intended purpose.
This is called method validation.
Possible validation characteristics include:
- specificity;
- accuracy;
- precision;
- linearity;
- measurement range;
- limit of detection;
- limit of quantification;
- robustness.
A method for identification does not automatically have to be suitable for exact quantification.
Therefore, it must be clear in advance which analytical question is being investigated.
What is the detection limit?
Every analytical method has a threshold below which a component cannot be detected reliably.
This is called the limit of detection.
A component that is not visible in a chromatogram is therefore not automatically completely absent.
The concentration may be lower than the detection limit.
In addition, certain substances may:
- do not respond to the detector used;
- fall outside the measurement range;
- are lost during sample preparation;
- are insufficiently separated.
The statement “not detected” is therefore not always the same as “not present.”
Can a chromatogram be manipulated?
A chromatogram must contain sufficient information to be assessed professionally.
Important data include:
- product name;
- batch number;
- analysis date;
- method used;
- detector settings;
- retention times;
- peak integration;
- laboratory data.
Only an image with one large peak and a percentage offers limited verifiability.
Integration settings can also influence which signals are included in the calculation.
Transparent reporting is therefore important.
What information should a reliable COA contain?
A Certificate of Analysis may include, among other things:
- peptide name;
- amino acid sequence;
- batch or lot number;
- production date;
- test date;
- HPLC result;
- chromatogram;
- mass spectrometric result;
- theoretical molecular mass;
- measured molecular mass;
- analytical methods used;
- name of the laboratory.
Not every COA contains all components.
The information required depends on the product and research objective.
A comprehensive COA can provide greater transparency, but its reliability also depends on the quality of the analysis.
Is high purity always necessary?
The required purity depends on the research objective.
In some analytical applications, very small quantities of secondary components can affect:
- measurement results;
- receptor research;
- cell research;
- reproducibility.
A higher purity level may then be desirable.
However, a higher percentage does not automatically mean that all other quality characteristics are better.
For example, a peptide with 99.5% HPLC purity may still:
- contain an incorrect quantity;
- have been stored incorrectly;
- be insufficiently identified;
- contain elevated residual moisture;
- have damaged packaging.
Quality should therefore be assessed multidimensionally.
Purity and batch differences
Each production batch has its own production and analysis process.
Therefore, purity results may differ between batches.
An analysis of one batch must not automatically be used as evidence for all future batches.
Batch-specific analysis supports:
- traceability;
- comparison;
- quality control;
- investigation of deviations.
The batch number on the vial must therefore match the number on the certificate of analysis.
Purity and stability
High initial purity does not guarantee that it will be maintained during long-term storage.
Possible degradation processes include:
- oxidation;
- hydrolysis;
- deamidation;
- aggregation.
The rate is influenced by:
- temperature;
- moisture;
- light;
- oxygen;
- amino acid sequence;
- packaging.
Stability studies can be used to track changes in the chromatographic profile over time.
Scientific limitations
No single analytical method independently provides a complete picture of peptide quality.
HPLC can provide important information about chromatographic purity, but it has limitations.
An HPLC percentage does not automatically prove:
- identity;
- exact peptide quantity;
- amino acid sequence;
- sterility;
- endotoxin content;
- biological activity;
- long-term stability.
That is why multiple analytical methods are combined.
A complete quality assessment may include:
- HPLC;
- mass spectrometry;
- quantitative assay;
- moisture analysis;
- stability studies;
- additional product-specific tests.
Summary
Peptide purity is an important quality parameter, but an HPLC percentage must be interpreted correctly.
A value of 99% generally means that approximately 99% of the integrated chromatographic signal has been assigned to the main peak.
It does not automatically mean that:
- 99% of the vial weight consists of peptide;
- the identity is fully confirmed;
- the stated quantity is correct;
- the material is sterile;
- all possible contaminants are excluded.
For a broader quality assessment, HPLC results must be combined with other data, such as:
- mass spectrometry;
- batch information;
- quantitative analysis;
- storage data;
- stability studies.
Peptide quality therefore consists of more than a single percentage.
Research disclaimer
Peptidera’s research peptides are offered exclusively for Research Use Only (RUO) and are intended for laboratory research and analytical applications.
Not intended for human or animal consumption, diagnostic use, therapeutic application, or self-administration.
Category:
Peptide knowledge & quality control
Related Peptidera products:
Lyophilized research peptides with batch identification and available analytical quality data
Related internal blogs:
- PB-0227 — Lyophilized peptides and lyophilization
- PB-0228 — Peptide vials and packaging integrity
- PB-0229 — Batch numbers and traceability
- What is a Certificate of Analysis?
- How are research peptides tested analytically?
Internal link suggestions:
- Link to PB-0229 on batch-specific analysis
- Link to the COA page for certificates of analysis
- Link to PB-0227 on stability and degradation
- Link to the research peptide collection
- Link to the independent laboratory testing page
Image file name:PB-0230-peptidezuiverheid-hplc-analyse.jpg